Efficacy and safety of hepatitis C antiviral therapy in moderate and severe chronic kidney disease
暂无分享,去创建一个
A. Goel | P. Abraham | R. Mahajan | V. Tamilarasi | J. Sivakumar | G. Basu | J. Ramachandran | P. Alagammai
暂无分享,去创建一个
A. Goel | P. Abraham | R. Mahajan | V. Tamilarasi | J. Sivakumar | G. Basu | J. Ramachandran | P. Alagammai